Senior Director, Market Access Strategy and Value Communication
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Intellia Therapeutics, a pioneer in gene editing, is preparing to launch its first gene editing therapies, focusing on groundbreaking treatments for rare and serious diseases, including hereditary angioedema (HAE) and transthyretin amyloidosis (ATTR). We are seeking an experienced Senior Director of Market Access Strategy and Value Communication to lead our strategic and tactical efforts in demonstrating the value of, and facilitating the adoption of, these therapies. This role is critical to ensuring successful product launches, fostering market access, site readiness, and building compelling narratives that resonate with diverse stakeholders, from healthcare providers, channel partners, and payers to patients and caregivers. This role will primarily serve as the access launch lead for HAE, with secondary responsibilities for future launches such as ATTR-PN & ATTR-CN.
